Focal Segmental Glomerulosclerosis (FSGS) represents the most common cause of acquired kidney failure in children and the frequency is increasing. The causes of FSGS remain largely unknown. There are several known genetic causes of FSGS. Mouse models with mutations in these same genes associated with FSGS in humans have been generated that show a very pronounced FSGS-like disease. We propose to derive a deeper understanding of the molecular pathways of pathogenesis of mutation-based FSGS by making use of the genetic power of the mouse coupled with the global gene expression analysis power of RNA-Seq/ microarrays, as outlined below:
Specific aim 1. We propose a RNA-Seq/microarray dissection of pathogenic pathways in each major cell type of the glomerulus in Actn4 mutant mice.
Specific aim 2. We propose a similar molecular dissection of the altered gene expression programs of each glomerular cell type in a bigenic mouse model of FSGS. ! Specific aim 3. As a complement to aims 1 and 2 we propose a proteomics analysis of the glomeruli of the FSGS model Actn4 and Cd2ap/Fyn mutant mice. This project will involve a multidisciplinary team of basic, translational and clinical investigators, and will prominently require the services of at least two of the proposed Center's Cores, namely the Gene Expression Core (Core A) and the Protomics Core (Core B).

Public Health Relevance

Focal Segmental Glomerulosclerosis (FSGS) represents the most common cause of acquired kidney failure in children and contributes to an enormous major impact on the U.S. public health and a major financial burden. Project 2 of this Center of Excellence will utilize multiple investigators and multiple Center Cores to provide critical results of studies aimed at understanding the causes of this dismal disease.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-G (M3))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Cincinnati Children's Hospital Medical Center
United States
Zip Code
Wang, Zhu; Ma, Shuangge; Zappitelli, Michael et al. (2016) Penalized count data regression with application to hospital stay after pediatric cardiac surgery. Stat Methods Med Res 25:2685-2703
Devarajan, Prasad; Jefferies, John Lynn (2016) PROGRESSION OF CHRONIC KIDNEY DISEASE AFTER ACUTE KIDNEY INJURY. Prog Pediatr Cardiol 41:33-40
Bertram, John F; Goldstein, Stuart L; Pape, Lars et al. (2016) Kidney disease in children: latest advances and remaining challenges. Nat Rev Nephrol 12:182-91
Soto, Karina; Campos, Pedro; Pinto, Iola et al. (2016) The risk of chronic kidney disease and mortality are increased after community-acquired acute kidney injury. Kidney Int 90:1090-1099
Abulaban, K M; Song, H; Zhang, X et al. (2016) Predicting decline of kidney function in lupus nephritis using urine biomarkers. Lupus 25:1012-8
Cooper, David S; Claes, Donna; Goldstein, Stuart L et al. (2016) Follow-Up Renal Assessment of Injury Long-Term After Acute Kidney Injury (FRAIL-AKI). Clin J Am Soc Nephrol 11:21-9
Jefferies, John Lynn; Devarajan, Prasad (2016) Early detection of acute kidney injury after pediatric cardiac surgery. Prog Pediatr Cardiol 41:9-16
Ma, Qing; Devarajan, Shiva R; Devarajan, Prasad (2016) Amelioration of cisplatin-induced acute kidney injury by recombinant neutrophil gelatinase-associated lipocalin. Ren Fail 38:1476-1482
Erkan, Elif; Zhao, Xueheng; Setchell, Kenneth et al. (2016) Distinct urinary lipid profile in children with focal segmental glomerulosclerosis. Pediatr Nephrol 31:581-8
Mina, Rina; Abulaban, Khalid; Klein-Gitelman, Marisa S et al. (2016) Validation of the Lupus Nephritis Clinical Indices in Childhood-Onset Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) 68:195-202

Showing the most recent 10 out of 66 publications